References
- Barlas S. Critics assail FDA medical device approval process: slow review time and safety are at issue.. P.T.. 2011;36(7):395–409.
- Palmer E. FDA hustles on opioid guidance to avoid budget meddling. Fierce Pharma. [Cited 2015 Mar 20]. Available from: http://www.fiercepharma.com/story/fda-hustles-opioid-guidance-avoid-budget-meddling/2015-03-20
- Manchikanti L, Atluri S, Candido K, et al. Hirsh J. Zohydro approval by the Food and Drug Administration: controversial or frightening? Pain Physician. 2014,;17(4):E437-50].
- Kapural L, Yu C, Doust MW, et al. Novel 10-kHz high frequency therapy (HF10) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain. Anesthesiology. 2015;123(No4):1–10.
- Deer TR, Levy R. A prospective, randomized, multi-center, controlled clinical trial to assess the safety and efficacy of the spinal modulation Axium® neurostimulator system in the treatment of chronic pain. Las Vegas (NV): Wiley; 2015 Dec.
- Deer TR, Krames E, Mekhail N, et al. Appropriate use of neurostimulation: new and evolving neurostimulation therapies and applicable treatment for chronic pain and selected disease states. Neuromodulation: Technol Neural Interface. 2014;17:599–615. doi:10.1111/ner.12204
- Shealy CN, Mortimer JT, Reswick JB. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth Analg. 1967;46(4):489–491.
- Pope JE, Deer TR, Kramer J. A systematic review: current and future directions of dorsal root ganglion therapeutics to treat chronic pain. Pain Med. 2013 Jun 26;14:1477–1496. doi:10.1111/pme.12171.
- Lynch PJ, McJunkin T, Eross E, et al. Case report: successful epiradicular peripheral nerve stimulation of the C2 dorsal root ganglion for postherpetic neuralgia. Neuromodulation. 2011 Jan;14(1):58–61.
- Slavin KV, Wess C. Trigeminal branch stimulation for intractable neuropathic pain: technical note. Neuromodulation. 2005;8(1):7–13.
- Abstracts of the 6th World Congress of the World Institute of Pain, WIP. 2012. Miami Beach, FL. Pain Pract. 2012 Feb;12(suppl 1):1–199.
- Grigsby E, Deer T, Weiner R, et al. Prospective, multicenter clinical trial studying dorsal root ganglion stimulation in the treatment of back pain. North American Neuromodulation Society Annual Meeting Proceedings; 2010 Dec 2–5, Las Vegas (NV).
- Kovalsky Y, Amir R, Devor M. Simulation in sensory neurons reveals a key role for delayed Na+ current in subthreshold oscillations and ectopic discharge: implications for neuropathic pain. J Neurophysiology. 2009;102:1430–1442.
- Krames ES. The role of the dorsal root ganglion in the development of neuropathic pain. Pain Med. 2014;15:1669–1685.
- Gemes G, Koopmeiners A, Rigaud M, et al. Failure of action potential propagation in sensory neurons: mechanisms and loss of afferent filtering in C-type units after painful injury. J Physiol. 2013;591:1111–1131.
- Liem L, Russo M, Huygen F, et al. One-year outcomes of spinal cord stimulation of the dorsal root ganglion in the treatment of chronic neuropathic pain. Neuromodulation. 2015 Jan;18(1):41–49. doi:10.1111/ner.12228. discussion 48-9. Epub 2014 Aug 21.
- ACCURATE Study. Clinical TRIALS website. Available from: https://clinicaltrials.gov/ct2/show/NCT01923285.
- Deer TR, Grigsby E, Weiner R. A prospective study of dorsal root ganglion stimulation for the relief of chronic pain. Neuromodulation. Technol Neural Interface. 2013; 16(1):67–72.